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Background: Loss of virulence is a phenotypic adaptation commonly seen in prokaryotic and eukaryotic pathogens.
This mechanism is not well studied, especially in organisms with multiple host and life cycle stages such as Babesia, a
tick-transmitted hemoparasite of humans and animals. B. bovis, which infects cattle, has naturally occurring virulent
strains that can be reliably attenuated in vivo. Previous studies suggest the virulence loss mechanism may involve
post-genomic modification. We investigated the transcriptome profiles of two geographically distinct B. bovis
virulent and attenuated strain pairs to better understand virulence loss and to gain insight into pathogen
adaptation strategies.
Results: Expression microarray and RNA-sequencing approaches were employed to compare transcriptome profiles of
two B. bovis strain pairs, with each pair consisting of a virulent parental and its attenuated derivative strain. Differentially
regulated transcripts were identified within each strain pair. These included genes encoding for VESA1, SmORFs,
undefined membrane and hypothetical proteins. The majority of individual specific gene transcripts differentially
regulated within a strain were not shared between the two strains. There was a disproportionately greater number of
ves genes upregulated in the virulent parental strains. When compared with their attenuated derivatives, divergently
oriented ves genes were included among the upregulated ves genes in the virulent strains, while none of the
upregulated ves genes in the attenuated derivatives were oriented head to head. One gene family whose specific
members were consistently and significantly upregulated in expression in both attenuated strains was spherical
body protein (SBP) 2 encoding gene where SBP2 truncated copies 7, 9 and 11 transcripts were all upregulated.
Conclusions: We conclude that ves heterodimer pair upregulation and overall higher frequency of ves gene
expressions in the virulent strains is consistent with the involvement of this gene family in virulence. This is logical
given the role of VESA1 proteins in cytoadherence of infected cells to endothelial cells. However, upregulation of some
ves genes in the attenuated derivatives suggests that the consequence of upregulation is gene-specific. Furthermore,
upregulation of the spherical body protein 2 gene family may play a role in the attenuated phenotype. Exactly how
these two gene families may contribute to the loss or gain of virulence is discussed.
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During pathogenesis, it is advantageous for a pathogen to
adjust to the shifting selective pressures exerted by the
host. Depending on the environmental milieu there may
be strong selection for specific pathogenic phenotypes
such as virulence or attenuation acquisition. These
phenotypic shifts may be achieved through sexual re-
production where novel recombinations often lead to
genome diversity [1]. However for many multi-stage
pathogens, this cannot occur during haploid life stages and
thus, they depend on genomic mutations or adaptations
through non-mutational mechanisms such as phenotypic
variation. Mutations associated with virulence (or attenu-
ation) are frequently documented in eubacteria [2-4]
and viruses [5,6]. However, there is a significant gap in
knowledge of virulence-associated gene mutations in
protozoa, including pathogens that have major impact
on global public and animal health. With increased
emphasis on the development and delivery of vaccines
for hemoparasites such as Babesia, Theileria, and
Plasmodium spp. [7-10], the ability to predictably and
stably attenuate pathogens would be a significant step
toward disease control strategies.
Babesia bovis is a tick-borne apicomplexan protozoan
responsible for causing bovine babesiosis [11]. Virulent
strains are capable of inducing cerebral babesiosis
where >90% of erythrocytes sequestered in cerebral
capillaries are infected with B. bovis parasites. The
resulting neurovirulent phenotype is clinically similar
to cerebral malaria caused by P. falciparum [12]. In
nature, there is a wide diversity of B. bovis virulent
phenotypes [13] but experimentally, attenuation can be
predictably induced in vivo by serial passages of viru-
lent B. bovis in a splenectomized host. The phenotypic
characteristic of neurovirulence is gradually lost, and
an attenuated derivative is obtained. Animals infected
with the attenuated derivative are protected upon viru-
lent parental challenge, indicating that determinants of
virulence may be modulated independently of epitopes
responsible for protective immunity. The absence of
the spleen during the attenuation process represents a
change in the host environment and subsequent change
in selection pressure. Although the mechanism of at-
tenuation is undetermined, one plausible explanation is
that circulating parasites are not cleared as they would
be in spleen-intact animals, resulting in the sequential
enrichment of a non-virulent parasite subpopulation.
Recent genomic comparison between three virulent
and attenuated B. bovis strain pairs indicate that there
are no consistent changes among the protein-coding
genes shared between strain pairs that could explain
the divergent phenotypes. However, an overall genome
reduction in all three attenuated strains was observed
[14]. These data suggest that (i) differences betweenparental and derivative strain pairs may lie in the non-
coding regions which influence transcriptomic variability
between virulent and attenuated strains, (ii) the loss of
genome content during the attenuation process is the
key to attenuation, or (iii) both.
In this study, we investigated the transcriptome profiles
of two geographically unrelated B. bovis strain pairs to
determine if attenuation is a result of common or distinct
strain-specific transcriptomic regulation. Although both
B. bovis strains were subjected to identical treatment/
selection pressure for attenuation acquisition, transcrip-
tome profiles of these two strains through attenuation were
different. Detailed discussion of differential gene expression
in their contribution to attenuation is discussed.
Results and discussion
T2Bo and L17 transcriptome approaches
In order to determine if virulence loss is controlled at
the transcriptional level, we compared the global tran-
scriptomes of two strain pairs of B. bovis. These strain
pairs, T2Bo_Virulent parent and Attenuated derivative
and L17_Virulent parent and Attenuated derivative,
are geographically distinct field isolates from Mexico
and Argentina, respectively [14]. Biological replicate
(BR) sample pairs were prepared for transcriptomic
analyses. For the generation of BR samples, animals
were inoculated with 1 × 107 parasitized erythrocytes.
When clinical symptoms associated with acute babesiosis
were observed and blood smears detected parasitemia,
infected blood was collected to establish short-term
(<30 days) culture to obtain sufficient starting material
for RNA extraction (TriZol and RNeasy Mini-elute kit,
Invitrogen. This short-term in vitro culture of virulent
and attenuated B. bovis followed by in vivo evaluation
of phenotype in infected animals were performed to
ensure the original phenotypes were maintained post
cultivation (unpublished data). Using the published T2Bo
genome (www.piroplasmaDB.org), we generated an expres-
sion microarray that represented >99.4% of the protein-
coding genes to investigate transcriptome differences
between T2Bo_V and _A. Due to the incomplete L17
genome, L17_V and _A transcriptome comparison was
performed by RNA-sequencing. The utilization of the
T2Bo genome-based microarray for L17 transcriptome
investigation would reflect gene expressions shared
between T2Bo and L17 and exclude L17-specific tran-
scripts as gene family member variations are known to
exist between different B. bovis strains [15].
Expression microarray analysis of B. bovis T2Bo
transcriptomes
Two independently produced biological replicates (BR)
were used to prepare for the virulent and attenuated
samples in the microarray analysis while a third BR
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data reveal the total number of detectable transcripts
ranged from 78 to 89% of all predicted transcripts depend-
ing on the BR samples (Table 1). Both biological replicate
sample pairs were highly correlated with coefficient of
determination (R2) trimmed signal values between both
BR sample pairs to be 0.95 and 0.98 (Figure 1A and B).
Microarray-based transcriptome analysis indicated that
61 genes in BR1 and 2 were differentially regulated at
significant levels (>2 fold difference, p < .05) between V
and A strain pairs (Figure 2A). This equates to 1.66% of
the total detectable transcripts within the genome.
Among them, 25 and 36 were upregulated in the virulent
(T2Bo_V) parent and its attenuated (T2Bo_A) derivative,
respectively (Figure 2A, Additional file 1: Table S4-5).
Seventy three percent of the transcripts upregulated in
T2Bo_V were variant erythrocyte surface antigen (ves)
genes followed by genes encoding for unspecified putative
membrane proteins at 14% (Figure 2B). Ves is the largest
gene family in B. bovis and encodes the variant erythrocyte
surface antigen (VESA)-1 in which divergently oriented
ves α and β are hypothesized to be transcribed at the
locus of active transcription, resulting in the expression
of a VESA1 αβ heterodimer on the erythrocyte surface
[16]. Microarray data reveal that seven and eight ves α
and β genes, respectively, were upregulated in T2Bo_V
and among them, three α and β are paired in divergently
oriented manner as described previously [16]. Al-Khedery
and Allred showed that divergently oriented ves α and
β are transcriptionally regulated coordinately and that
they function in antigenic variation and cytoadhesion.
Ves genes that are not oriented in the same manner
may act as donor sequences in segmental conversion.
Interestingly, although there were upregulated ves α
and β genes in T2Bo_A as well, none of them (nα = 2
and nβ = 3) are paired in divergently oriented manner
on the chromosomes. Based on this finding, it is plaus-
ible to hypothesize that (i) transcription of ves α and β
divergently oriented pair might be impaired in T2Bo_A
or (ii) that parasites expressing divergently oriented ves α
and β may not be numerous enough for their transcripts
to be detected by the array approach in the samples.
Nonetheless, either scenario may contribute to theTable 1 Summary of the T2Bo genome-based microarray stat
T2Bo_A1
# genes detected 3,210
% genes detected 86.8
T2
# differentially expressed genes*
# differentially expressed genes with 2x difference
*Student T-test, p < .01; DE, differentially expressed.observed lack of neurovirulence in animals in animals
infected with T2Bo_A.
In addition to ves genes that were upregulated in
both parental virulent and attenuated T2Bo, two (9%)
smORF (small open reading frame) genes were upregulated
in T2Bo_V while 13 smORF (36%) were upregulated
significantly in T2Bo_A (Figure 2B-C). SmORF is the
second largest gene family with 43 members in T2Bo
[17]. Although the function of the SmORF proteins is
unknown, the proximity of these genes with ves led to
speculation that their expression may be coordinated
with ves’ [18]. However, since only two smORFs but 16
ves genes in T2Bo_V, and 13 smORFs but five ves genes
in T2Bo_A, were upregulated, and none of the smORF
gene locations were associated with those of ves, smORF
gene transcriptional regulation may be independent from
ves after all. The higher frequency of upregulated smORF
gene transcripts in T2Bo_A is noteworthy, but its tran-
scription in B. bovis is likely to be independent of the
virulence/attenuation phenotype (Figure 2B-C).
Additional differentially regulated genes in T2Bo
(V or A) were those encoding for hypothetical proteins,
putative membrane proteins, spherical body protein
(SBP) 2 truncated copies (11%, n = 4) and 1-deoxy-D-
xylose-5-phosphate reductoisomerase (DOXPR) (3%, n = 1)
(Figure 2C). Hypothetical and putative membrane proteins
are two protein groups whose transcripts were found to
be upregulated in the virulent and attenuated strains,
though none of the specific protein group members
were common between T2Bo_V and _A. Sbp2 truncated
copies were exclusively upregulated in T2Bo_A by as
much as 7 fold (2.8-7.8 folds) as compared to T2Bo_V
(Table 2 and Additional file 1: Table S5). These transcripts
belong to the sbp2 gene family which encodes a large
parasite-derived, exported protein that resides on the
cytoplasmic side of the infected cell [19,20]. SBP2 is
Babesia-specific [21,22] and is valuable in diagnostic
procedures in suspected Babesia-infected cattle [23].
SBP2 and its family members’ functions are currently
unknown (Figure 2B) and its upregulation in additional
Babesia will reinforce its contribution in attenuation
acquisition (see RNA-sequencing data below). Doxpr




Bo_A1 vs. V1 T2Bo_A2 vs. V2
749 773
89 64
Figure 1 Correlation plots of trimmed signal intensities between the two T2Bo biological replicate (BR) sample pairs. Signal intensities
are the sum of the pixel signals in the area of interest minus the scaled 2-pixel median background. The intensities are then median-normalized
by calculating the median of all spots. Comparisons of each virulent pair (A) and each attenuated pair (B) are shown.
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used to generate the microarray data. DOXPR is a critical
component in the non-mevalonate pathway (MEP) in the
B. bovis apicoplast lumen [24]. This pathway is conserved
among apicoplast-containing apicomplexans and consists
of six major participants in addition to DOXPR. Although
doxpr was upregulated significantly in T2Bo_A (Figure 3),
none of the other MEP participants’ transcripts were
upregulated in T2Bo_A. This was unexpected and one
could only speculate DOXPR upregulation in T2Bo_A
may be involved in a pathway other than MEP in this
attenuated strain and its regulation is irrelevant to viru-
lence loss in Babesia. Further evidence supporting suchFigure 2 Global distribution of differentially regulated transcripts in v
breakdown of the putative functions of these transcripts. (A) Sixty-on
upregulated in the virulent and attenuated strain, respectively. (B) Signifi
putative functions. (C) Significantly upregulated genes in the attenuated
for the variant erythrocyte surface antigen (VESA)1; sbp2, gene encoding
reading frame protein; doxpr, gene encoding for 1-deoxy-D-xylose-5-phoimplication comes from the RNA-sequencing analysis
in L17_A which will be discussed later in the study.
Among the randomly selected transcripts chosen for
microarray data validation in this study (Figure 3), 70%
confirmed significant differential regulation while 20%
showed differential regulation but were not statistically
significant and one transcript showed the opposite
trend from the array data (II007790) (p < .05). Including
additional validated genes (manuscript in prep) [25],
greater than 95% of randomly chosen transcripts were
validated suggesting that the microarray assessment of
the T2Bo virulent and attenuated transcriptome profiles
is representative. One possible explanation to why weirulent and attenuated T2Bo Babesia bovis strain pair and the
e genes were differentially expressed where 41% and 59% were
cantly upregulated genes in the virulent strain with corresponding
derivative strain and their predicted functions. Ves, gene encoding
for spherical body protein 2; smORF, gene encoding for small open
sphate reductoisomerase.
Table 2 Spherical body protein 2 gene family members (SBP2) that were significantly upregulated in attenuated (A)
T2Bo and L17 strains
Gene ID Annotation T2Bo_A (fold changes)* L17_A (fold changes)*
BBOV_III005600 SBP2 truncated copy 1 ND 3.3
BBOV_III005830 SBP2 truncated copy 4 7.8 ND
BBOV_III005840 SBP2 truncated copy 5 ND 2.5
BBOV_III006460 SBP2 truncated copy 7 2.8 2.3
BBOV_III006500 SBP2 truncated copy 9 3.9 8.3
BBOV_III006540 SBP2 truncated copy 11 4.6 3.7
ND, not detected to be significantly upregulated; *, fold changes is in reference to the respective virulent parental strains.
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expressed transcripts may be due to sample pairs used in
BR preparation are not clonal, thus may exhibit population
variability. Transcripts whose differential expression
profiles are not shared between biological replicates
may not contribute in the attenuation process.
RNA-sequencing analysis on B. bovis L17 transcriptomes
To investigate if specific differentially expressed transcript
profile of one B. bovis strain pair (T2B0_V and _A strain)
is also observed in a geographically unrelated strain
pair, transcriptomic profile of an additional B. bovis
(L17_V and _A) strain pair was obtained. Three thousand
six hundred and thirty-one transcripts were detected
using Illumina-based RNA-sequencing technique (96.75%
of predicted transcripts in the genome) and compared
between L17_V and _A BR samples (n = 3). Correlation
plots using counts per million (cpm) of the three BRs
ranged between 0.98 and 1.00 and reflect minimal biasFigure 3 Validation of ten differentially expressed genes using quant
sample sets as templates. Transcripts were randomly selected for validati
using a 1-way ANOVA with Bonferroni post-test analysis (Graphpad Prism v
of a house keeping gene, BBOV_III004820, thus, the final data are represent
the higher the expression. III 010740, gene encoding for 1-deoxy-D-xylose-5
for spherical body protein 2 truncated copies 7 and 9 respectively; II007790
I004520 and III003100, genes encoding for variant erythrocyte surface (ves)
and III002360, gene encoding for a putative membrane protein.in sample preparation (Figure 4). With p value set at
1x10-5 as before, four hundred eighty-four transcripts
showed significant differentially expression between the
L17_V and _A samples. These differentially expressed
transcripts were further scrutinized by selecting for
those whose |logFC| value was greater than 1 (i.e. at
least 2 fold difference) (Figure 5), reducing the total
number of significant upregulated transcripts in B. bovis
L17_V and _A to 116 and 66, respectively (Figure 6A).
Absolute log fold changes (|logFC|) of these differen-
tially expressed transcripts ranged between 5.2 and 9.3
(Additional file 1: Tables S6-S7). Eight highly differen-
tially regulated genes were chosen for validation using
an independently prepared BR L17 sample pair (Figure 7).
The number of transcripts chosen for validating the
RNA-sequencing results is consistent with previous
studies [26] and validation results corroborated with the
RNA-sequencing data. Detectable differentially expressed
transcripts reported by the array were approximately 3xitative PCR on independently generated biological replicate
on and their expression considered significantly regulated (*) if p < .05
.5.0a). Expression values as cycle thresholds were normalized to those
ed as cycle threshold ratio (CT ratio) where the lower the ratio value,
-phosphate reductoisomerase; III006460 and III006500, genes encoding
, gene encoding for a hypothetical protein; III006070, III001500,
α subunits; III006080 and IV001490, genes encoding for ves β subunits
Figure 4 Correlation plots of signal intensities as counts per million (cpm) were compared between the three L17 biological replicate
sample pairs. Comparisons of each virulent pair (A-C) and each attenuated pair (D-F) are shown.
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Two possibilities may account for the difference. First,
RNA-sequencing technology is known to be superior at
detecting lower transcript levels than microarray [27]. Sec-
ond, there are more differentially expressed transcripts in
the L17 strain pairs. In this study, it is likely that height-
ened sensitivity of RNA-sequencing is the reason whyFigure 5 Plot smear presentation of differentially expressed gene dis
that are plotted left or right of the dotted red lines are those that were up
counts per millions.more differentially expressed transcripts were detected in
the L17 strain pairs. This high sensitivity of RNA-
sequencing technology was able to detect approximately
97% of the total predicted transcripts in the B. bovis gen-
ome. This implies that B. bovis asexual stages utilize a
large proportion of the predicted protein encoded genes.
This, however, does not suggest that these transcripts aretribution between virulent and attenuated L17 samples. Genes
- or down-regulated by at least two fold. FC, fold changes and CPM,
Figure 6 Global distribution of differentially regulated transcripts in virulent and attenuated L17 Babesia bovis strain pair and the
breakdown of the putative functions of these transcripts. (A) A total of 182 (116 + 66) genes were differentially expressed where 64% and
46% were upregulated in the virulent and attenuated strains, respectively. (B) Distribution of upregulated genes in the virulent strain and their
putative protein functions. (C) Distribution of upregulated genes in the attenuated derivative strain and their putative functions. Ves, gene
encoding for the variant erythrocyte surface antigen (VESA)1; sbp2, gene encoding for spherical body protein 2; smORF, gene encoding for the
small open reading frame protein; misc., miscellaneous genes of various putative functions (as listed in Additional file 1: Table S4-S7).
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the remaining protein encoded transcripts used for other
stages. Majority of the detected transcripts in both the
virulent and attenuated strain pair (92%) are likely used in
stages other than the asexual stages as they were notFigure 7 Validation of RNA-sequencing data with quantitative PCR us
highly regulated transcripts were randomly selected for validation and con
Bonferroni post-test analysis (Graphpad Prism v.5.0a). Expression values as c
BBOV_III004820, thus, the final data are represented as cycle threshold ratio
I003010, gene encoding for merozoite surface antigen 2a1; III000400, gene
gene encoding for a membrane protein; III004490, gene encoding for a hypo
for spherical body protein 2 truncated copies 5, 7 and 11, respectively; IV0121statistically and significantly different in their regulation
between the strain pair.
Included among the 116 upregulated genes in L17_V
were genes encoding for hypothetical proteins (n = 38,
33%), SmORFs (n = 18, 16%), VESA1 (n = 30, 26%), hexoseing independently generated biological replicate sample set. Only
sidered significantly (*) expressed if p < .05 using a 1-way ANOVA with
ycle thresholds were normalized to those of a house keeping gene,
(CT ratio) where the lower the ratio value, the higher the expression.
encoding for a small open reading frame protein (SmORF); III002360,
thetical protein; III005840, III006460 and III006540 were genes encoding
20, gene encoding for a membrane protein.
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(n = 28, 24%) (Figure 6B). Approximately seven percent
(6.9%) of the total upregulated genes in L17_V were
also upregulated in T2Bo_V. These were four ves
(I005140, I004520, IV001500 and IV007980), two smORFs
(I001370, I001160) and a hypothetical protein-encoding
gene (I001350). Two of these upregulated ves transcripts
in L17_V (α:I004520; β:I004510) form a ves αβ “LAT”
pair. The remaining upregulated virulent-associated ves
(α or β) shared between T2Bo and L17 virulent strains
were not paired in a divergently oriented manner which
are referred to as singletons. Also interestingly is that only
a single ves divergently oriented αβ pair was detected
to be significantly upregulated in L17_V as opposed to
three upregulated divergently oriented ves αβ pairs in
T2Bo_V. As mutually exclusive transcription of this
gene family occurs [28], the detection of three ves αβ
pairs may suggest that the parasites which eventually
express these “functional” VESA1 heterodimers represent
the dominant members within the heterologous T2Bo
virulent population while the detection of a single ves αβ
pair in L17_V sample may imply that only one dominant
parasite which expresses functional VESA1 αβ is present
within the L17 virulent population. If divergently oriented
ves αβ pair’s transcription and subsequent expression
are associated with virulence severity, then T2B0_V
may be more virulent than L17_V. This datum may also
suggest that L17_V contains a less diverse population
than T2Bo_V. Unpaired ves α/β subunits, regardless of
their expression in virulent or attenuated L17 strain, may
still contribute to antigenic variability through segmental
gene conversion [16]. The higher mean frequency of
upregulated ves in L17_V than T2Bo_V, regardless of
paired or singleton status, is likely to be due to greaterFigure 8 Comparison of the mean frequencies of major differentially
bovis strains. Ves, gene encoding for the variant erythrocyte surface antige
copies and smORF, gene encoding for a small open reading frame protein.sensitivity of the RNA-sequencing technique (Figure 8).
Furthermore, there is a possibility that the failure of ob-
serving any putative “functional” ves αβ transcripts in both
attenuated strains could be due to these parasites being
sequestered within capillaries as peripheral blood was
collected for the preparation of sample pairs [29].
The pattern of differential expression of smORF genes
in the two strains is unique to each strain. There were
fewer upregulated smORF genes in T2Bo_V than in L17_V
with little overlap between the strains, suggesting that
subsequent SmORF proteins may not play a significant
role in the virulence phenotype (Figure 8).
Among the genes encoding proteins that were signifi-
cantly upregulated in L17_A (n = 66), hypothetical (30%,
n = 20), putative membrane (18%, n = 12), SmORF (9%,
n = 9) and VESA1 (5%, n = 3) remain the major groups
(Figure 6C) with 10.6% of the 66 of the total upregulated
genes in L17_A also upregulated in T2Bo_A. As similarly
found in the T2Bo_A transcriptome profile, the upre-
gulated hypothetical and putative membrane protein
encoding genes likely participate in strain-specific activ-
ities. Their involvement in virulence loss is still possible
but this idea is further dampened by the fact that some
of these L17_A-associated upregulated genes were found
to be upregulated in T2Bo_V (e.g. I001360, II002820,
II007850 and III002360) (Additional file 1: Table S4
and S7).
Genes encoding for SBP2 truncated copies (1, 4, 5, 7, 9
and 11) were upregulated in both attenuated strains
(Figure 8). Specifically, sbp2 truncated copies 4, 7,9 and
11 were upregulated in T2Bo_A while truncated copies
1, 5, 7 9 and 11 were upregulated in L17_A. This makes
sbp2 truncated copies 7, 9 and 11 upregulated in both
attenuated strains (Table 2, Additional file 1: Table S5regulated gene families between virulent and attenuated Babesia
n (VESA)1; sbp2, gene encoding for spherical body protein 2 truncated
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9 and 11 indicated that they share extremely high se-
quence homology (e-200–887, data not shown) and thus
sbp2_4 that was upregulated in T2Bo_A could potientially
be substituted by sbp2_1 and 5 in L17_A. Again, exactly
how the truncated copies participate in SBP2’s function
and why their upregulation may contribute to virulence
loss are unknown. SBP2 has been reported to reside in
the cytoplasmic side of the infected erythrocytes. It is
possible that this protein family interacts with either
parasite- or host-derived proteins, a scenario not foreign
to the apicomplexan field (e.g. knob-associated histidine
rich protein, KAHRP [30]). Perhaps upregulation of SBP2
family genes and subsequent overexpression of the proteins
disrupt the normal matrix of protein-protein interaction,
resulting in virulence loss. Experiments investigating
into such a phenomenon are currently underway.
In addition to transcripts described above, some mis-
cellaneous transcripts encoding proteins were exclu-
sively upregulated in L17_A by at least 2 fold. These
include transcripts encoding for NifU-domain contain
protein, HesB-domain containing protein, HAD hydrolase,
u6-snRNA associated sm-like Lsm2 protein and oxi-
doreductase NAD-binding domain containing protein
(Additional file 1: Table S7). NifU-domain containing
proteins perform basic cellular functions and are among
the most highly conserved proteins [31]. HesB-domain
containing proteins participate in the formation of
metallo-sulfur cluster assembly [32]. HAD hydrolases
function in housekeeping detoxification, modulation of
sugar-phosphate balance in plants [33] while u6-snRNA
associated sm-like Lsm2 proteins have been reported to
be involved in RNA processing and may function in a
chaperone-like manner in eukaryotes [34]. Lastly, oxi-
doreductase NAD-binding proteins are known to be
enrolled in both aerobic and anaerobic metabolism
which include glycolysis, tricarboxylic acid (TCA) cycle,
oxidative phosphorylation, and amino acid metabolism
[35]. As all these transcripts were solely upregulated in
L17_A and not in T2Bo_A, we hypothesize that these
transcripts and subsequent proteins, if translated, likely
function in processes unrelated to virulence loss.
It was unexpected and disappointing that none of the
differentially regulated transcripts with some annotation
data involved in immune evasion, infection or reproduct-
ion efficiency were detected. This, by no means, suggests
that such transcripts were not involved as they may be
one of the putative membrane or the hypothetical proteins
that were differentially regulated in both strains.
Conclusions
Two B. bovis strain pairs (T2Bo and L17) were used to
investigate if virulence loss in protozoans is controlled at
the transcriptional level through common strategies. Forthis study, we utilized a virulent parental phenotype and
its attenuated derivative of each strain. We developed
and independently validated data generated from an
expression microarray for T2Bo and RNA-sequencing
for L17, the latter of which yielded three times more
differentially regulated genes in the L17 strain pair. We
attribute this difference to the heightened sensitivity of
RNA-sequencing. Although some differentially expressed
transcript families between the two strains were shared,
the majority of the specific differentially expressed
members were different, suggesting that strain-specific
members within common gene families may participate
in virulence loss.
We identified upregulation of ves αβ pairs in both
virulent strains and hypothesize that these “actively and
transcriptionally coordinated” ves αβ pairs expressed in
the virulent strains may contribute to the virulence
phenotype. This is consistent with our previous study
where we showed that additional in vivo serial passage is
required to attenuate T2Bo than L17 and more severe
clinical pathologies are associated with animals infected
with T2Bo_V than those infected with L17_V, all suggest
that T2Bo may be more virulent than L17 [14]. Specific-
ally, we identified more divergently oriented and actively
transcribed αβ pairs in T2Bo_V than L17_V and specu-
lated that T2Bo may be a more heterologous B. bovis
population with higher virulence than L17. The obser-
vation that none of the putative αβ pairs were shared
between the two virulent strains could simply mean
that different strains utilize different ves αβ pairs for
the same function.
We also demonstrated that genes encoding for SBP2
truncated copies were significantly upregulated in both
attenuated strains, and among these, the specific genes
sbp2_7, 9 and 11 were upregulated in both. We speculated
that sbp2 truncated copies 1, 4 and 5, which were not
shared, may be used substitutively by the parasite strains
in attenuation. Although function of SBP2 is not known,
we hypothesized that the upregulation of sbp2 truncated
copies may result in the over expression of the proteins
and affect binding partners in the cytoplasm of the
infected erythrocytes.
There were additional upregulated transcripts with
limited annotational information but they were all strain
specific in their expression and may not contribute to
the phenotype change due to attenuation.
In summary, our study demonstrates that two B. bovis
strains underwent identical manipulation/exposure to
selection eventually resulting in virulence loss. Despite
some similar gene expression profiles shared between
the two attenuated derivatives, much of the differential
gene regulation is strain specific. Outcome of this study
demonstrates the independent adaptation of individual
B. bovis strains to similar environmental milieu. These
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of the virulent parental strains. Ongoing experiments
exploring population dynamics of these virulent B. bovis
are currently underway.
Methods
Parasite strains, in vitro cultivation of B. bovis and
RNA isolation
Two geographical distinct, virulent (V) B. bovis (T2Bo and
L17 strains) and the generation of their attenuated (A) de-
rivatives were propagated as previously described [14]. In-
fected blood was collected and frozen stabilates were
prepared and stored until use. All animals used for the gen-
eration of parasitized erythrocytes were used according to
all guideline approved by the Animal Use Committee of the
Instituto Nacional de Tecnología Agropecuaria, Argentina.
Two and three BR sample pairs for T2Bo and L17 B. bovis
strains were used in the generation of transcriptome pro-
files, respectively. These were prepared at different times
during a 1-year duration using different animals. For micro-
array and RNA-sequencing validation, additional BR sam-
ple pairs were generated (see below). Quality of the total
RNA was evaluated using an Agilent Bioanalyzer.
Microarray sample preparation
Ten micrograms of total RNA from T2Bo V1-2 and A1-2
were converted to enriched mRNA using Applied Biosys-
tem’s (Ambion) MicrobExpressTm Kit (AM1905). The
manufacturer’s protocol was followed. Enriched mRNA
was analyzed by the Agilent 2100 Bioanalyzer. One - 2.5 μg
of enriched mRNA from 10 μg of total RNA was obtained.
The enriched mRNA (200 ng) was converted to cRNA
using Applied Biosystem’s (Ambion) MessageAmp™ II-
Bacteria RNA Amplification Kit (AM1790). Amino-allyl-
UTP was incorporated into the cRNA during the IVT re-
action as described in the manufacturer’s protocol. One
hundred μg from 200 ng was obtained. The amine reactive
dye Alexa Fluor 555 (Invitrogen A32756) was coupled to
cRNA (amino allyl moieties) following the manufac-
turer’s instructions. Unincorporated dye was removed
using RNeasy Mini Columns (Qiagen 74104). The Qia-
gen quick clean-up protocol was followed. cRNA
coupled to fluorescent dye was fragmented using pro-
prietary technology. The expected mean fragment
length was 100–125 nucleotides. Fragmented cRNA was
considered sufficiently fragmented for use on MYcroarrays
if the mean fragment length less than 200 nucleotides.
Custom 3 × 20 K B. bovis arrays
Custom B. bovis (Bb) MYcroarrays were manufactured
(Mycroarray.com). Briefly, each MYcroarray slide contains
three arrays. Each 20 K Bb array had 21,280 potential
addresses for features. On each 20 K Bb array, there
were 18,490 spots that contain 45mer probes for Bbgenes, 2,110 features were “empty” (i.e., they contain no
probe), 608 features contain MYcroarray in-house QC
probes and 72 features contain positive control probes for
assessing hybridization and washing stringency. There
were 5 identical replicates, i.e. technical replicates, of each
unique Bb probe sequence. A total of 3,698 Bb genes were
interrogated on each array, one probe sequence per
gene. Designated probes that could cross hybridize due
to conserved sequences were noted (Additional file 1:
Table S1). A total of 24 genes (23 apicoplast-encoded
and 1 nuclear-encoded) were not represented in the
array due to the failure of single gene-specific probe
design (Additional file 1: Table S2).
Single color hybridizations
cRNA derived from all samples was coupled to Alexa
Fluor 555. Each target (5 μg) was hybridized separately
to one array. Hybridization was performed for >18 hrs at
50°C in a proprietary hybridization buffer and subsequent
wash steps in MYcorarray’s 1X wash solutionwas carried
out twice at 22°C for 3 min, once at 50°C for 3 min with
gentle agitation. The arrays were allowed to cool to room
temperature in fresh 1X wash solution, transferred to
0.25× wash solution for 30 sec, spun dry in a microarray
centrifuge and were scanned in an Axon 4000B Scanner
(Molecular Devices) set at 5 micron pixel resolution.
The photo multiplier tube (PMT) setting was adjusted
to detect the maximum dynamic range of signal (0 to
65,000). This was accomplished by increasing the PMT
setting until just a few features (spots) were saturated.
The background turned out to be unusually high on two
slides. Consequently, the washing process was repeated
in exactly the same way with one exception. The 50°C
wash was increased to 58°C. Following the second wash
procedure, the arrays were scanned at a PMT setting of
380 in the 532 nm (“green”) channel.
Data analysis
Data were extracted from the scanned images using
GenePix Pro Software (version 6.1.0.4). The GAL file
(“Load Array List” in GenePix) was positioned over the
image. For signal extraction, circular feature indicators
(30 μm diameter) were centered over each spot. Median
feature pixel intensity was extracted. Flagged features
were handled as follows: if a spot was manually flagged
as “bad” (a value of −100 in the “flags” field of the .gpr
file) no present call was made for this probe and the
signal value was replaced with a blank field. Only one
array had manually flagged “bad” features (sample A2)
and only 303 features were flagged “bad” out of a total
of 18,490 (1.6%) Bb features. Since a trimmed mean
(see below) was used to estimate the signal for each
probe set, the absent value for flagged spots was dropped.
Saturated features were handled as follows: To ascertain
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ting was adjusted until saturation was achieved. In this
study, a PMT setting of 380 resulted in some saturated
features. There were a total of 211 features with saturation
equal to or greater than 10%. This is about 0.2% of the Bb
features in the study. The features with ≥10% saturation
were handled identically to features that were flagged
“bad”. To correct for background, an equation was used:
background corrected signal = [Max (signal–background,
0.1) × SF] + C, where C =25 and SF = Scale Factor. In other
words, if background subtraction produced a value less
than zero, 0.1 replaced the background corrected signal.
The background corrected signal was then multiplied
by the scaling factor (see normalization below) to adjust
for inter-array brightness differences. Finally, the entire
signal distribution was shifted to the right by adding
constant value (25) to all background corrected and scaled
signal values. The shift of the entire signal distribution
to the right helped to avoid confoundment of differen-
tiate low signal values from residual noise in the system
background noise.
To adjust for differences in dye incorporation, a scale
factor was created to equalize signal across all arrays.
Only features that met the following criteria were called
normalization features (NF) and were used to calculate
the scale factor: only Bb features with less than 10%
saturated pixels; median signal more than six fold
above background and observed in all 6 arrays. There
were 12,182 qualifying normalization features. The average
signal for the normalization features was calculated for
each array while a scale factor (SF) for each array was
calculated as follows:
SF ¼ Average NF median signalð ÞBrightest array
=Average NF median signalð Þarray
A scaled F532 median signal for each probe was calcu-
lated by multiplying the background adjusted median
F532 signal for each feature by the scale factor for each
array. Scaling is a minimalistic normalization approach.
There are numerous normalization techniques for single
color microarray analysis.
A trimmed mean statistic was used to estimate the
signal value for each probe set. The median pixel signal
for each feature was used after background subtraction
and scaling. For each probe set (n = 5) the maximum
and minimum value were dropped and the remaining
three values were averaged. If there were less than five
probe signal values due to either a bad or saturated feature,
the trimmed mean was simply calculated on the remaining
probes. Using the trimmed mean to estimate signal on
an array, is a very simple yet robust approach that helps
to mitigate the influence of outlier values and helps
normalize intra-array measurements.An estimation of whether or not a transcript was de-
tected by a probe was calculated. The estimation is a
“present” call. The present call is based on the signal
value for each gene (probe) relative to the local median
background level surrounding each spot. For each probe,
if the signal was greater than five times the background
signal, then the transcript was considered “present”.
A list of differentially regulated genes was generated.
Briefly, each sample group (either A1 vs V1 or A2 vs V2)
was compared separately. The filtering criteria were as
follows:
 1. For each gene, at least 4 out of 5 probes had to
have a present call in one condition (either “A” or “V”).
 2. For the genes that satisfied the present call filter
(#1 above), a Student’s T-test was performed on the
Log2 transformed signal data and only genes with at
least p < 0.05 were considered.
 3. Finally, a gene was added to the list if both a fold
change ratio (A/V was used arbitrarily) of at least
1.5 combined with a T-test p < 0.01.
RNA-sequencing
Total RNA from L17_V 1–3 and _A1-3 samples were
used for the constructions of the libraries as described
by the manufacturer (Illumina TruSeq v.2) and carried
out at the Fred Hutchison Genomic Center, Seattle. All
six samples were multiplexed in a single lane with 50 cycles
pair-end runs. The estimated reads per library were 25
million. Following the sequencing process, image analysis
and base calling were performed with Illumina RTA v1.13.
Reads were aligned to B. bovis T2Bo genome (www.piro-
plasmaDB.org) using Tophat v.2.0.4 and Bowtie v.0.12.8.
Counts were generated using htseq-count v.0.5.3p9 with
the default “union” overlapping mode. Certain genes were
removed from consideration if count < 1 per 2 samples.
Therefore, the starting # of genes was 3,754 and the
post-filtered # of genes was 3,630. Differentially expressed
genes pairing the samples by their biological source
were identified using edgeR v.2.6.12. Genes were considered
significantly and differentially regulated if |log fold
change (FC)| ≥ 1 & false detection rate (FDR) < 5%.
Additional file 1: Table S3 summaries the htseq counts
of the 6 L17 samples.
Array and RNA- sequencing validation
In order to validate the data obtained by the microarray
and RNA-sequencing, qPCR was performed using an
independently generated T2Bo or L17 BR sample pair
and BBOV_III004820 to normalize the qPCR assay.
BBVO_III004820 encodes for a putative topoisomerase
II and although its orthologue in P. falciparum has been
shown to have a four-fold fluctuation between different
asexual stages within the erythrocytes [36], its transcript
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PCR [25]. Primers used for the validation are listed in
Additional file 1: Table S8. All primers were confirmed
for specificity via cloning and sequencing prior to use
(data not shown). Four technical replicates were per-
formed per gene. Cycle thresholds (CT) for a selection
of differentially regulated genes were measured. The
selection criteria of genes used for the validation process
are based on the list of genes that was identified to be
significantly differentially expressed in both strains.
However, differentially expressed genes selected for
validation for the RNA-sequencing data were those
that were highly differentially expressed. Significant
differentially expressed transcripts with low copy num-
bers detected by RNA-sequencing likely will not be
detectable via qPCR due to its lower sensitivity thresh-
old compared to RNA-sequencing. Upon normalization of
the qPCR, relative values of expression were represented
as cycle threshold ratios (CT ratio) as previously described
[25]. A 1-way ANOVA with Bonferroni post-test analysis
was conducted (Graphpad Prism v.5.0a). The list of
differentially expressed genes chosen for validation for
both assays is in Additional file 1: Table S8.
Availability of supporting data
All the microarray data have been incorporated into the
corresponding genomic data of the B. bovis strain (www.
piroplasmadb.org) while the RNA-sequencing data have
been deposited in NCBI’s Gene Expression Omnibus and
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array whose probes may cross hybridize. Table S2. Babesia bovis genes
that are not represented in the transcriptome array. Table S3. Summary
of the Illumina based RNA-sequencing on Babesia bovis L17 V1-3 and A1-
3 samples. Table S4. Transcripts that are significantly upregulated (≥2
fold) in Babesia bovis T2Bo virulent strain. Table S5. Transcripts that are
significantly upregulated (≥ 2 fold) in Babesia bovis T2Bo attenuated
strain. Table S6. Top 40 transcripts that are significantly upregulated (≥ 2
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ated strain. Table S8. Specific primers used for the validation of differen-
tially regulated gene transcripts in T2Bo and L17 Babesia bovis strains.
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